Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
353.10
+7.06 (2.04%)
Sep 11, 2025, 1:10 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $285.27 billion as of September 12, 2025. Its market cap has increased by 5.42% in one year.
Market Cap
285.27B
Enterprise Value
319.11B
Revenue
79.83B
Ranking
n/a
PE Ratio
24.06
Stock Price
$353.10
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 285.27B, an increase of 3,157.01%. That is a compound annual growth rate of 10.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 289.56B | 28.00% |
Dec 30, 2024 | 226.23B | -3.34% |
Dec 29, 2023 | 234.04B | -9.76% |
Dec 30, 2022 | 259.35B | -22.73% |
Dec 30, 2021 | 335.62B | 12.23% |
Dec 30, 2020 | 299.05B | 8.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 815.18M |
Elite Pharmaceuticals | 739.37M |
Tian'an Technology Group | 675.94M |
Glass House Brands | 608.81M |
CytoDyn | 424.27M |
Northwest Biotherapeutics | 378.39M |
American Oncology Network | 353.52M |